|
1
|
Norrby SR, Nord CE and Finch R; European
Society of Clinical Microbiology and Infectious Diseases, : Lack of
development of new antimicrobial drugs: A potential serious threat
to public health. Lancet Infect Dis. 5:115–119. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hegstad K, Langsrud S, Lunestad BT, Scheie
AA, Sunde M and Yazdankhah SP: Does the wide use of quaternary
ammonium compounds enhance the selection and spread of
antimicrobial resistance and thus threaten our health? Microb Drug
Resist. 16:91–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spellberg B, Blaser M, Guidos RJ, Boucher
HW, Bradley JS, Eisenstein BI, Gerding D, Lynfield R, Reller LB,
Rex J, et al: Infectious Diseases Society of America (IDSA):
Combating antimicrobial resistance: Policy recommendations to save
lives. Clin Infect Dis. 52 Suppl 5:S397–S428. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ganz T: Defensins: Antimicrobial peptides
of innate immunity. Nat Rev Immunol. 3:710–720. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Selsted ME and Ouellette AJ: Mammalian
defensins in the antimicrobial immune response. Nat Immunol.
6:551–557. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Midorikawa K, Ouhara K, Komatsuzawa H,
Kawai T, Yamada S, Fujiwara T, Yamazaki K, Sayama K, Taubman MA,
Kurihara H, et al: Staphylococcus aureus susceptibility to innate
antimicrobial peptides, β-defensins and CAP18, expressed by human
keratinocytes. Infect Immun. 71:3730–3739. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang D, Biragyn A, Kwak LW and Oppenheim
JJ: Mammalian defensins in immunity: More than just microbicidal.
Trends Immunol. 23:291–296. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang D, Chertov O, Bykovskaia SN, Chen Q,
Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM, et
al: β-defensins: Linking innate and adaptive immunity through
dendritic and T cell CCR6. Science. 286:525–528. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Niyonsaba F, Iwabuchi K, Matsuda H, Ogawa
H and Nagaoka I: Epithelial cell-derived human β-defensin-2 acts as
a chemotaxin for mast cells through a pertussis toxin-sensitive and
phospholipase C-dependent pathway. Int Immunol. 14:421–426. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
García JR, Jaumann F, Schulz S, Krause A,
Rodríguez-Jiménez J, Forssmann U, Adermann K, Klüver E, Vogelmeier
C, Becker D, et al: Identification of a novel, multifunctional
β-defensin (human β-defensin 3) with specific antimicrobial
activity. Its interaction with plasma membranes of Xenopus oocytes
and the induction of macrophage chemoattraction. Cell Tissue Res.
306:257–264. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng R, Feng F, Meng F, Deng C, Feijen J
and Zhong Z: Glutathione-responsive nano-vehicles as a promising
platform for targeted intracellular drug and gene delivery. J
Control Release. 152:2–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu SP, Zhou L, Lakshminarayanan R and
Beuerman RW: Multivalent antimicrobial peptides as therapeutics:
Design principles and structural diversities. Int J Pept Res Ther.
16:199–213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gan Q, Wang T, Cochrane C and McCarron P:
Modulation of surface charge, particle size and morphological
properties of chitosan-TPP nanoparticles intended for gene
delivery. Colloids Surf B Biointerfaces. 44:65–73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li L and Xu B: Multivalent vancomycins and
related antibiotics against infectious diseases. Curr Pharm Des.
11:3111–3124. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Z, Deshazer H, Rice AJ, Chen K, Zhou C
and Kallenbach NR: Multivalent antimicrobial peptides from a
reactive polymer scaffold. J Med Chem. 49:3436–3439. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arnusch CJ, Branderhorst H, de Kruijff B,
Liskamp RM, Breukink E and Pieters RJ: Enhanced membrane pore
formation by multimeric/oligomeric antimicrobial peptides.
Biochemistry. 46:13437–13442. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Young AW, Liu Z, Zhou C, Totsingan F,
Jiwrajka N, Shi Z and Kallenbach NR: Structure and antimicrobial
properties of multivalent short peptides. MedChemComm. 2:308–314.
2011. View Article : Google Scholar
|
|
18
|
Roy K, Mao HQ, Huang SK and Leong KW: Oral
gene delivery with chitosan - DNA nanoparticles generate
immunologic protection in a murine model of peanut allergy. Nat
Med. 5:387–391. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Templeton NS, Lasic DD, Frederik PM, Strey
HH, Roberts DD and Pavlakis GN: Improved DNA: Liposome complexes
for increased systemic delivery and gene expression. Nat
Biotechnol. 15:647–652. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Almofti MR, Harashima H, Shinohara Y,
Almofti A, Baba Y and Kiwada H: Cationic liposome-mediated gene
delivery: Biophysical study and mechanism of internalization. Arch
Biochem Biophys. 410:246–253. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu Z, Wan X, Zhang W, Wang Z, Peng R, Tao
F, Cai L, Li Y, Jiang Q and Gao R: Synthesis of biodegradable
polycationic methoxy poly (ethylene
glycol)-polyethylenimine-chitosan and its potential as gene
carrier. Carb Polym. 78:46–53. 2009. View Article : Google Scholar
|
|
22
|
Li ZT, Guo J, Zhang JS, Zhao YP, Lv L,
Ding C and Zhang XZ: Chitosan-graft-polyethylenimine with improved
properties as a potential gene vector. Carb Polym. 80:254–259.
2010. View Article : Google Scholar
|
|
23
|
Horton RM, Hunt HD, Ho SN, Pullen JK and
Pease LR: Engineering hybrid genes without the use of restriction
enzymes: Gene splicing by overlap extension. Gene. 77:61–68. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wiegand I, Hilpert K and Hancock RE: Agar
and broth dilution methods to determine the minimal inhibitory
concentration (MIC) of antimicrobial substances. Nat Protoc.
3:163–175. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu YY, Wang Z, Cai L, Wang G, Yang X, Li Y
and Gao R: Synthesis and characterization of methoxy poly(ethylene
glycol)-O-chitosan-polyethylenimine for gene delivery. Carb Polym.
81:269–274. 2010. View Article : Google Scholar
|
|
26
|
Bodmeier R, Chen HG and Paeratakul O: A
novel approach to the oral delivery of micro- or nanoparticles.
Pharm Res. 6:413–417. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mosmann TR and Sad S: The expanding
universe of T-cell subsets: Th1, Th2 and more. Immunol Today.
17:138–146. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kidd P: Th1/Th2 balance: The hypothesis,
its limitations, and implications for health and disease. Altern
Med Rev. 8:223–246. 2003.PubMed/NCBI
|
|
29
|
Yamada H, Nakashima Y, Okazaki K, Mawatari
T, Fukushi JI, Kaibara N, Hori A, Iwamoto Y and Yoshikai Y: Th1 but
not Th17 cells predominate in the joints of patients with
rheumatoid arthritis. Ann Rheum Dis. 67:1299–1304. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lassmann H and Ransohoff RM: The CD4-Th1
model for multiple sclerosis: A crucial re-appraisal. Trends
Immunol. 25:132–137. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kis J, Engelmann P, Farkas K, Richman G,
Eck S, Lolley J, Jalahej H, Borowiec M, Kent SC, Treszl A, et al:
Reduced CD4+ subset and Th1 bias of the human iNKT cells
in Type 1 diabetes mellitus. J Leukoc Biol. 81:654–662. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Seki Y, Inoue H, Nagata N, Hayashi K,
Fukuyama S, Matsumoto K, Komine O, Hamano S, Himeno K,
Inagaki-Ohara K, et al: SOCS-3 regulates onset and maintenance of
T(H)2-mediated allergic responses. Nat Med. 9:1047–1054. 2003.
View Article : Google Scholar : PubMed/NCBI
|
